Trials / Completed
CompletedNCT00178269
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Rochester · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out how effectively cervix cancer is controlled when radiation is combined with low-dose chemotherapy (Taxotere) . The use of low-dose Taxotere, once per week, with radiation is a new treatment for cervical cancer. This study will also see how well this treatment regimen can be tolerated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | docetaxel | |
| PROCEDURE | Radiation Therapy |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2006-06-01
- First posted
- 2005-09-15
- Last updated
- 2009-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00178269. Inclusion in this directory is not an endorsement.